<doc>
  <docmeta id="113hr1608ih">
    <bill congress="113" type="hr" number="1608" version="ih"/>
    <revision size="5372" annotations="0" id="6" commit-time="2013-05-03T18:56:43+00:00" committer="favila" doc="113hr1608ih/6.xml" status="complete">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H00ADAB20FC0A4586B37C305C7575E8F8" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 1608 IH: Cody Miller Initiative for Safer Prescriptions Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-04-17</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1608</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130417">April 17, 2013</action-date>
			<action-desc>
        <sponsor name-id="O000169">Mr. Owens</sponsor> introduced
			 the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To require the Secretary of Health and Human Services to
		  promulgate regulations regarding the authorship, content, format, and
		  dissemination of Patient Medication Information to ensure patients receive
		  consistent and high-quality information about their prescription medications
		  and are aware of the potential risks and benefits of prescription
		  medications.</official-title>
	</form>
	<legis-body id="HA4BF7606683C44D696CAB59EE1712346" style="OLC">
		<section id="HB773DC02B2C54AFAB6E4E27455B9C893" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Cody Miller Initiative for Safer
			 Prescriptions Act</short-title>
        </quote>.</text>
		</section>
    <section id="H55F490FBB29C4F75BB748BB5443A3347">
      <enum>2.</enum>
      <header>Patient
			 medication information for prescription drugs</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V">Chapter V of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/351">
            <cato:entity-ref entity-type="uscode" value="usc/21/351/etseq">21 U.S.C. 351 et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505D">section 505D</cato:entity-ref>
			 the following:</text>
			<quoted-block display-inline="no-display-inline" id="HA9C2307A2D2343038E053B46411D0F45" style="OLC">
				<section id="HAD2253C6AC8B4BC6ABC6B665A642A1AC">
          <enum>505E.</enum>
          <header>Patient
				medication information for prescription drugs</header>
					<subsection id="HEEA084337D004A22B04DCBC96A7DDA2E">
            <enum>(a)</enum>
            <header>In
				general</header>
            <text>Not later than 2 years after the date of enactment of
				this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue regulations regarding the authorship,
				content, format, and dissemination requirements for patient medication
				information (referred to in this section as <term>PMI</term>) for drugs subject
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1)</cato:entity-ref>.</text>
					</subsection>
          <subsection id="HB6E2356BF3C94931BB9F312F6AC0B944">
            <enum>(b)</enum>
            <header>Content</header>
            <text>The
				regulations promulgated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505E/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall require that the PMI with
				respect to a drug—</text>
						<paragraph id="H9B2ED450473C43BDA6334CD902EE7525">
              <enum>(1)</enum>
              <text>be scientifically
				accurate and based on the professional labeling approved by the Secretary and
				authoritative, peer-reviewed literature; and</text>
						</paragraph>
            <paragraph id="HEE0486A2048544BCBAF46925A5B02DA1">
              <enum>(2)</enum>
              <text>includes
				nontechnical, understandable, plain language that is not promotional in tone or
				content, and contains at least—</text>
							<subparagraph id="HA1FED0A8CBD5482E9B30314A9359DCEE">
                <enum>(A)</enum>
                <text>the established
				name of drug, including the established name of such drug as a listed drug (as
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A">section 505(j)(2)(A)</cato:entity-ref>) and as a drug that is the subject of an
				approved abbreviated new drug application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j">section 505(j)</cato:entity-ref> or of an
				approved license for a biological product submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351/ss:k">section 351(k) of the
				Public Health Service Act</cato:entity-ref>, if applicable;</text>
							</subparagraph>
              <subparagraph id="H27786D7739F847D7A7A842A73DF5D14E">
                <enum>(B)</enum>
                <text>drug uses and
				clinical benefits;</text>
							</subparagraph>
              <subparagraph id="HCE9D20F411F74398A54D1258E479C0CE">
                <enum>(C)</enum>
                <text>general directions
				for proper use;</text>
							</subparagraph>
              <subparagraph id="H61AE7A0428EF4996A4F864C74C974D25">
                <enum>(D)</enum>
                <text>contraindications,
				common side effects, and most serious risks of the drug, especially with
				respect to certain groups such as children, pregnant women, and the
				elderly;</text>
							</subparagraph>
              <subparagraph id="H549590FA9B494C03ACAC795CDA0DFA8C">
                <enum>(E)</enum>
                <text>measures patients
				may be able to take, if any, to reduce the side effects and risks of the
				drug;</text>
							</subparagraph>
              <subparagraph id="HD23F07B74B044319B10D15AC6E4166E8">
                <enum>(F)</enum>
                <text>when a patient
				should contact his or her health care professional;</text>
							</subparagraph>
              <subparagraph id="HA05BD0F26C8F4162AC00E1E12136C04C">
                <enum>(G)</enum>
                <text>instructions not
				to share medications, and, if any exist, key storage requirements, and
				recommendations relating to proper disposal of any unused portion of the drug;
				and</text>
							</subparagraph>
              <subparagraph id="HFAC505D67AB84501833FF023D484625B">
                <enum>(H)</enum>
                <text>known clinically
				important interactions with other drugs and substances.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="HEA1803EB3EC84E178D73C6EC60AA475E">
            <enum>(c)</enum>
            <header>Timeliness,
				consistency, and accuracy</header>
            <text>The regulations promulgated under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505E/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall include standards related to—</text>
						<paragraph id="H5FED5F0EF1614EB98268D9B4DD3238BE">
              <enum>(1)</enum>
              <text>performing timely
				updates of drug information as new drugs and new information becomes
				available;</text>
						</paragraph>
            <paragraph id="HA4D6FACD290645DA9DD23A8421DBCF7B">
              <enum>(2)</enum>
              <text>ensuring that
				common information is applied consistently and simultaneously across similar
				drug products and for drugs within classes of medications in order to avoid
				patient confusion and harm; and</text>
						</paragraph>
            <paragraph id="HBD11F566DCD440D69E96BAFF9082F216">
              <enum>(3)</enum>
              <text>developing a
				process, including consumer testing, to assess the quality and effectiveness of
				PMI in ensuring that PMI promotes patient understanding and safe and effective
				medication use.</text>
						</paragraph>
          </subsection>
          <subsection id="H30AFA2E286424FB7AFD0EDCCACFE0791">
            <enum>(d)</enum>
            <header>Electronic
				repository</header>
            <text>The regulations promulgated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505E/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall
				provide for the development of a publicly accessible electronic repository for
				all PMI documents and content to facilitate the availability of
				PMI.</text>
					</subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section id="H3B6BE4D679DC487A92BAF9A062ACB5B4">
      <enum>3.</enum>
      <header>Publication on
			 internet Web site</header>
      <text display-inline="no-display-inline">The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> shall publish on the Internet Web site
			 of the Food and Drug Administration a link to the Daily Med Web site
			 (http://dailymed.nlm.nih.gov/dailymed) (or any successor Web site).</text>
		</section>
  </legis-body>
</bill>
</doc>